OXB to participate in investor conferences
Oxford Biomedica to present at investor conferences in November 2025.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 27 October 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that members of its senior management team, including Dr. Frank Mathias, Chief Executive Officer, and Dr. Lucy Crabtree, Chief Financial Officer, will participate in the following upcoming investor conferences and events. Details are provided below.
Conferences
Stifel Healthcare Conference (New York)
- Date: 11 November 2025
- Fireside chat: 13:20 ET / 18:20 GMT
Jefferies Global Healthcare Conference (London)
- Date: 18 November 2025
- Presentation: 11:30 GMT / 06:30 ET
Events
Jefferies C-Suite "Back to School" Fireside Chat (Virtual)
Date: 4 November 2025
Live webcasts and recordings of presentations, where available, will be accessible under 'Results, Reports, Presentations & Webcasts' in the Investor Relations section of OXB's website at www.oxb.com.
For details of other upcoming financial events, please refer to the Company's investor calendar at https://oxb.com/investor-events/.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.